US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aevi Genomic Medicine Inc

0.1659

+0.0000

Volume:- -

Turnover:- -

Market Cap:12.89M

PE:-0.56

High:0.1659

Open:0.1659

Low:0.1659

Close:0.1659

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Aevi Genomic Medicine Inc

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.medgenics.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Aevi Genomic Medicine, Inc., a clinical stage medical technology company, engages in the research and development of products in the field of biotechnology and associated medical equipment in the United States. The company develops transduced autologous restorative gene therapy (TARGT), a platform to provide protein and peptide therapies to treat a range of chronic diseases. Its lead product candidate is MDGN-201, which is an endogenous erythropoietin secretion TARGT that is in the Phase I/II clinical trials for the treatment of end stage renal diseases and other indications, including ß-thalassemia. The company was formerly known as Medgenics, Inc. and changed its name to Aevi Genomic Medicine, Inc. in December 2016. Aevi Genomic Medicine, Inc. was founded in 2000 and is based in Wayne, Pennsylvania.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GNMX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Aevi Genomic Medicine Inc","latestPrice":0.1659,"timestamp":1580763600000,"preClose":0.1659,"halted":4,"volume":0,"delay":0,"floatShares":67896168,"shares":77713782,"eps":-0.295664,"marketStatus":"Delisted","change":0,"latestTime":"05-01 10:29:10 EDT","open":0.1659,"high":0.1659,"low":0.1659,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.295664,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"NASDAQ","adjPreClose":0.1659,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":67896168,"roa":"-104.54%","roe":"-372.06%","lyrEps":-0.501371,"shares":77713782,"dividePrice":0,"high":0.1659,"amplitude":0,"preClose":0.1659,"low":0.1659,"week52Low":0.11,"pbRate":"38.83","week52High":0.347,"institutionHeld":0,"latestPrice":0.1659,"eps":-0.295664,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.295664,"open":0.1659},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.medgenics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0289},{"period":"1year","weight":0.1047},{"period":"ytd","weight":-0.0538}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aevi Genomic Medicine, Inc., a clinical stage medical technology company, engages in the research and development of products in the field of biotechnology and associated medical equipment in the United States. The company develops transduced autologous restorative gene therapy (TARGT), a platform to provide protein and peptide therapies to treat a range of chronic diseases. Its lead product candidate is MDGN-201, which is an endogenous erythropoietin secretion TARGT that is in the Phase I/II clinical trials for the treatment of end stage renal diseases and other indications, including ß-thalassemia. The company was formerly known as Medgenics, Inc. and changed its name to Aevi Genomic Medicine, Inc. in December 2016. Aevi Genomic Medicine, Inc. was founded in 2000 and is based in Wayne, Pennsylvania.","exchange":"NASDAQ","name":"Aevi Genomic Medicine Inc","nameEN":"Aevi Genomic Medicine Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-14","symbol":"GNMX","fiscalQuarterEnding":"2019/09","expectedEps":-0.05,"name":null,"time":"","type":"earning","dateTimestamp":1573707600000,"reportTimeType":"","actualEps":-0.06},{"market":"US","date":"2019-08-13","symbol":"GNMX","fiscalQuarterEnding":"2019/06","expectedEps":-0.1,"name":null,"time":"","type":"earning","dateTimestamp":1565668800000,"reportTimeType":"","actualEps":-0.06},{"market":"US","date":"2019-05-14","symbol":"GNMX","fiscalQuarterEnding":"2019/03","expectedEps":-0.1,"name":null,"time":"","type":"earning","dateTimestamp":1557806400000,"reportTimeType":"","actualEps":-0.07},{"market":"US","date":"2018-11-01","symbol":"GNMX","fiscalQuarterEnding":"2018/09","expectedEps":-0.16,"name":null,"time":"","type":"earning","dateTimestamp":1541044800000,"reportTimeType":"","actualEps":-0.12},{"market":"US","date":"2018-08-02","symbol":"GNMX","fiscalQuarterEnding":"2018/06","expectedEps":-0.15,"name":null,"time":"","type":"earning","dateTimestamp":1533182400000,"reportTimeType":"","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{}}}